Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEPT8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ASAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFAIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DRA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOLGA8A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FOXP4-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLSCR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC30A4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARNTL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BHLHE22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYNE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR107 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TANC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PNMA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on